Themis Medicare Ltd.

THEMISMED

₹138.53

0.69% (0.95)

Market Cap

₹1,286 Cr.

P/E

27.88

About

Themis Medicare Ltd. is a research-based pharmaceutical company specializing in manufacture of a wide range of products for application areas like Pain Management, Critical Care and Anti-Infectives. T… Read more

Themis Medicare Ltd. is a research-based pharmaceutical company specializing in manufacture of… Read more

Low

115

52W Range

High

317

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Operational Metrics

R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Themis Medicare Ltd. Business

What does Themis Medicare do?

Themis Medicare Ltd. is a research-based pharmaceutical company focusing on Pain Management, Critical Care, and Anti-Infectives. It develops differentiated products for patient benefit.

Who are the competitors of Themis Medicare?

Themis Medicare major competitors are Hester Biosciences, Shree Ganesh Remed., Kopran, NGL Fine-Chem, SMS Pharmaceuticals, Bajaj Healthcare, IOL Chem & Pharma.
Market Cap of Themis Medicare is ₹1,267 Crs.
While the median market cap of its peers are ₹1,533 Crs.

Is Themis Medicare financially stable compared to its competitors?

Themis Medicare seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release				Sep	Sep Dec
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Sep Dec
Conference Call			Mar Sep	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Themis Medicare Ltd.

Interview With Dr Sachin Patel, CEO, Themis Medicare and Gujarat Themis Biosyn - Sensei Kujaku

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Themis Medicare Ltd.